Literature DB >> 10741772

Clinical course and prognosis of patients with chronic obstructive pulmonary disease.

K Nishimura1, M Tsukino.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a basically benign disease, but the prognosis is so poor that the mortality rate is similar to some malignant diseases. Depending on the disease severity, the 5-year mortality rate of patients with COPD varies from 40 to 70%. The three major causes of death have been identified as COPD itself, lung cancer, and cardiovascular disease. The following factors have been reported to be related to survival: FEV1 (especially the maximal attainable lung function), age, gender, PaO2, PaCO2, body weight, and comorbidity. There have been several large-scale randomized clinical trials to examine the prophylactic effects of inhaled anti-cholinergics and inhaled corticosteroids on the annual decline in FEV1. However, unfortunately, in all of the published studies, these drugs had no effect on the annual decline in FEV1.

Entities:  

Mesh:

Year:  2000        PMID: 10741772     DOI: 10.1097/00063198-200003000-00008

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  11 in total

1.  Admissions with chronic obstructive pulmonary disease after publication of national guidelines.

Authors:  M G Kelly; J S Elborn
Journal:  Ir J Med Sci       Date:  2002 Jan-Mar       Impact factor: 1.568

2.  Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Carolyn L Rochester; H Klar Yaggi; Thomas M Gill
Journal:  Respir Med       Date:  2010-03-03       Impact factor: 3.415

3.  Mortality after Respiratory Isolation of Nontuberculous Mycobacteria. A Comparison of Patients Who Did and Did Not Meet Disease Criteria.

Authors:  Shannon A Novosad; Emily Henkle; Sean Schafer; Katrina Hedberg; Jennifer Ku; Sarah A R Siegel; Dongseok Choi; Christopher G Slatore; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2017-07

Review 4.  Palliative care in chronic obstructive pulmonary disease: a review for clinicians.

Authors:  David A Seamark; Clare J Seamark; David M G Halpin
Journal:  J R Soc Med       Date:  2007-05       Impact factor: 5.344

5.  The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Carolyn L Rochester; H Klar Yaggi; Thomas M Gill
Journal:  Am J Respir Crit Care Med       Date:  2009-12-17       Impact factor: 21.405

6.  Defining chronic obstructive pulmonary disease in older persons.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Carolyn L Rochester; H Klar Yaggi; Thomas M Gill
Journal:  Respir Med       Date:  2009-05-21       Impact factor: 3.415

7.  Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial.

Authors:  Yves Lacasse; Sarah Bernard; Frédéric Sériès; Van Hung Nguyen; Jean Bourbeau; Shawn Aaron; François Maltais
Journal:  BMC Pulm Med       Date:  2017-01-09       Impact factor: 3.317

Review 8.  Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena.

Authors:  David Halpin
Journal:  COPD       Date:  2008-06       Impact factor: 2.409

9.  Mortality in a cohort of complex patients with chronic illnesses and multimorbidity: a descriptive longitudinal study.

Authors:  I Martín-Lesende; E Recalde; P Viviane-Wunderling; T Pinar; F Borghesi; T Aguirre; M Recio; M E Martínez; J Asua
Journal:  BMC Palliat Care       Date:  2016-04-12       Impact factor: 3.234

10.  Obesity might be a good prognosis factor for COPD patients using domiciliary noninvasive mechanical ventilation.

Authors:  Hilal Altinoz; Nalan Adiguzel; Cuneyt Salturk; Gokay Gungor; Ozlem Mocin; Huriye Berk Takir; Feyza Kargin; Merih Balci; Oner Dikensoy; Zuhal Karakurt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.